1. Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
2. Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
3. Amgen, Thousand Oaks, California
4. National Heart and Lung Institute, Imperial College London, London, United Kingdom
5. Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo, Norway
6. Deputy Editor, JAMA Cardiology